316 related articles for article (PubMed ID: 16271105)
21. Severe hemolytic disease of the newborn due to anti-Js(b).
Gordon MC; Kennedy MS; O'Shaughnessy RW; Waheed A
Vox Sang; 1995; 69(2):140-1. PubMed ID: 8585197
[TBL] [Abstract][Full Text] [Related]
22. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
23. [Severe hemolytic disease of the newborn as a result of late and undiagnosed alloimmunization--case report].
Drozdowska-Szymczak A; Czaplińska N; Borek-Dziecioł B; Kociszewska-Najman B; Bartkowiak R; Wielgoś M
Ginekol Pol; 2014 Mar; 85(3):226-9. PubMed ID: 24783436
[TBL] [Abstract][Full Text] [Related]
24. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
25. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
[TBL] [Abstract][Full Text] [Related]
26. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
27. Severe hemolytic disease of the newborn due to anti-Cw.
Byers BD; Gordon MC; Higby K
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
[TBL] [Abstract][Full Text] [Related]
28. Severe intrauterine hemolysis due to anti-C(w).
Chu HP; Kanagalingam D; Chan DK
Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
[TBL] [Abstract][Full Text] [Related]
29. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.
Lakhwani S; Machado P; Pecos P; Coloma M; Rebollo S; Raya JM
Transfus Apher Sci; 2011 Aug; 45(1):9-11. PubMed ID: 21723196
[TBL] [Abstract][Full Text] [Related]
30. Erythroblastosis fetalis produced by anti-k.
Bowman JM; Harman FA; Manning CR; Pollock JM
Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
[TBL] [Abstract][Full Text] [Related]
31. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
Lindenburg IT; van Kamp IL; van Zwet EW; Middeldorp JM; Klumper FJ; Oepkes D
BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
[TBL] [Abstract][Full Text] [Related]
32. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
[TBL] [Abstract][Full Text] [Related]
33. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
34. The management of hemolytic disease in the fetus and newborn.
Bowman J
Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
[TBL] [Abstract][Full Text] [Related]
35. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
[TBL] [Abstract][Full Text] [Related]
36. Severe haemolytic disease of the newborn due to anti-Js(b).
Stanworth S; Fleetwood P; de Silva M
Vox Sang; 2001; 81(2):134-5. PubMed ID: 11555475
[TBL] [Abstract][Full Text] [Related]
37. [The Ko phenotype and fetal-maternal allo-immunization].
Fourmaintraux A; Vitrac D; Mariette JB; Brunel F
Arch Fr Pediatr; 1993 Nov; 50(9):779-81. PubMed ID: 8060208
[TBL] [Abstract][Full Text] [Related]
38. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
[TBL] [Abstract][Full Text] [Related]
39. A young woman with a transfusion-related pregnancy complication.
Gustavsen A; Njerve IU; Sitras V; Haugen G; Tølløfsrud PA; Akkök ÇA
Tidsskr Nor Laegeforen; 2020 Jan; 140(1):. PubMed ID: 31948214
[TBL] [Abstract][Full Text] [Related]
40. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
van Dijk BA; Hirasing RA; Overbeeke MA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
